0001437749-19-015054.txt : 20190731 0001437749-19-015054.hdr.sgml : 20190731 20190731163515 ACCESSION NUMBER: 0001437749-19-015054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190522 FILED AS OF DATE: 20190731 DATE AS OF CHANGE: 20190731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morton Mawae CENTRAL INDEX KEY: 0001715607 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14602 FILM NUMBER: 19989227 MAIL ADDRESS: STREET 1: 7473 MAKA'A STREET CITY: HONOLULU STATE: HI ZIP: 96825 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYANOTECH CORP CENTRAL INDEX KEY: 0000768408 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 911206026 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 73-4460 QUEEN KAAHUMANU HWY STREET 2: SUITE 102 CITY: KAILUA KONA STATE: HI ZIP: 96740 BUSINESS PHONE: 8083261353 MAIL ADDRESS: STREET 1: 73-4460 QUEEN KAAHUMANU HWY STREET 2: SUITE 102 CITY: KAILUA-KONA STATE: HI ZIP: 96740 4 1 rdgdoc.xml FORM 4 X0306 4 2019-05-22 0000768408 CYANOTECH CORP CYAN 0001715607 Morton Mawae 73-4460 QUEEN KAAHUMANU HWY #102 KAILUA-KONA HI 96740 1 Former CEO and Director Common Stock 2019-07-15 4 A 0 11400 0 A 13015 D Common Stock 2019-07-15 4 D 0 4104 0 D 8911 D Common Stock 2019-05-22 4 M 0 1993 0 A 2026 D Common Stock 2019-05-22 4 M 0 411 0 D 1615 D Restricted Stock Units 2019-05-22 4 M 0 1993 0 D Common Stock 1993 0 D Stock Options 3.3500 Common Stock 75000 75000 D Stock Options 3.8300 Common Stock 45000 45000 D Grant of shares made pursuant to the Separation Agreement between the issuer and the reporting person, dated as of June 3, 2019 (the "Separation Agreement"), a copy of which is attached to and made a part of the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 7, 2019; transaction exempt from Section 16(b) of the Securitities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16b-3 thereunder. Shares withheld pursuant to the Separation Agreement to satisfy tax withholding obligations; transaction exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. Pursuant to Separation Agreement, all restricted stock units are fully vested as of May 22, 2019. Pursuant to Separation Agreement, all stock options are fully vested as of May 22, 2019. Pursuant to Separation Agreement, all stock options will expire on December 6, 2019. /s/ Jesse Debban, by Power of Attorney 2019-07-31